Bill Snyder

double helix
August 21, 2014

New technique accelerates genome editing process

It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease.

By Bill Snyder
colorful x-ray of brain
August 14, 2014

Team takes 4-D look at brain receptor’s role

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory.

By Bill Snyder
August 7, 2014

Conn lands Javits Neuroscience Investigator award

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders.

By Bill Snyder
August 5, 2014

Technique brings spinal cord neural signaling into focus

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.

By Bill Snyder
August 5, 2014

Drug discovery clues in network map

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

By Bill Snyder
microscope
July 31, 2014

Doris Duke awards enhance clinical research training

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.

By Bill Snyder
July 24, 2014

Team spots trigger for rare diarrheal disease in infants

Researchers at Vanderbilt University, the University of Arizona and Phoenix Children’s Hospital have discovered what triggers a rare but devastating diarrheal disease in newborns that is fatal without intravenous feeding or intestinal transplant.
By Bill Snyder
July 24, 2014

Magnuson honored for role in Beta Cell Biology Consortium

Mark Magnuson, M.D., Louise B. McGavock Professor of Molecular Physiology and Biophysics at Vanderbilt University, has received a national leadership award for the Beta Cell Biology Consortium (BCBC), a major team science initiative.
By Bill Snyder
July 24, 2014

VU’s technology transfer efforts gain steam

Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year.
By Bill Snyder
July 24, 2014

Team effort boosts study of tachycardia syndrome

Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month.
By Bill Snyder
July 24, 2014

Colon cancer’s protein signatures identified

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.
By Bill Snyder
July 17, 2014

Breast tissue growth protein may promote cancer: study

A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found.
By Bill Snyder
1 … 94 95 96 97 98 … 115